168 related articles for article (PubMed ID: 34292397)
1. Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis.
Banerjee G; Forsgard N; Ambler G; Keshavan A; Paterson RW; Foiani MS; Toombs J; Heslegrave A; Thompson EJ; Lunn MP; Fox NC; Zetterberg H; Schott JM; Werring DJ
J Neurol; 2022 Mar; 269(3):1470-1475. PubMed ID: 34292397
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy.
Banerjee G; Ambler G; Keshavan A; Paterson RW; Foiani MS; Toombs J; Heslegrave A; Dickson JC; Fraioli F; Groves AM; Lunn MP; Fox NC; Zetterberg H; Schott JM; Werring DJ
J Alzheimers Dis; 2020; 74(4):1189-1201. PubMed ID: 32176643
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.
Renard D; Wacongne A; Ayrignac X; Charif M; Fourcade G; Azakri S; Le Floch A; Bouly S; Marelli C; Arquizan C; Hirtz C; Gabelle A; Thouvenot E; Lehmann S
J Alzheimers Dis; 2016; 50(3):759-764. PubMed ID: 26757185
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cerebrospinal fluid profiles in Alzheimer's disease with multiple cerebral microbleeds and cerebral amyloid angiopathy-related inflammation.
Kimura A; Takemura M; Saito K; Yoshikura N; Hayashi Y; Harada N; Nishida H; Nakajima H; Inuzuka T
J Neurol; 2017 Feb; 264(2):373-381. PubMed ID: 28000005
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal Fluid Profile of Tau, Phosphorylated Tau, Aβ42, and Aβ40 in Probable Cerebral Amyloid Angiopathy.
Grangeon L; Paquet C; Guey S; Zarea A; Martinaud O; Rotharmel M; Maltête D; Quillard-Muraine M; Nicolas G; Charbonnier C; Chabriat H; Wallon D
J Alzheimers Dis; 2022; 87(2):791-802. PubMed ID: 35367960
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
van den Berg E; Nilsson J; Kersten I; Brinkmalm G; de Kort AM; Klijn CJM; Schreuder FHBM; Jäkel L; Gobom J; Portelius E; Zetterberg H; Brinkmalm A; Blennow K; Kuiperij HB; Verbeek MM
J Alzheimers Dis; 2023; 92(2):467-475. PubMed ID: 36776062
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy.
De Kort AM; Kuiperij HB; Alcolea D; Kersten I; Versleijen AAM; Greenberg SM; Stoops E; Schreuder FHBM; Klijn CJM; Lleó A; Claassen JAHR; Verbeek MM
Alzheimers Res Ther; 2021 Sep; 13(1):160. PubMed ID: 34560885
[TBL] [Abstract][Full Text] [Related]
8. Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis.
Charidimou A; Friedrich JO; Greenberg SM; Viswanathan A
Neurology; 2018 Feb; 90(9):e754-e762. PubMed ID: 29386280
[TBL] [Abstract][Full Text] [Related]
9. Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.
Noguchi-Shinohara M; Komatsu J; Samuraki M; Matsunari I; Ikeda T; Sakai K; Hamaguchi T; Ono K; Nakamura H; Yamada M
J Alzheimers Dis; 2017; 55(3):905-913. PubMed ID: 27802236
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Biomarkers in Dementia Patients with Cerebral Amyloid Angiopathy.
Li YF; Ge FF; Zhang Y; You H; Zhang ZX
Chin Med Sci J; 2015 Sep; 30(3):170-3. PubMed ID: 26564416
[TBL] [Abstract][Full Text] [Related]
11. Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy.
De Kort AM; Kuiperij HB; Marques TM; Jäkel L; van den Berg E; Kersten I; van Berckel-Smit HEP; Duering M; Stoops E; Abdo WF; Rasing I; Voigt S; Koemans EA; Kaushik K; Warren AD; Greenberg SM; Brinkmalm G; Terwindt GM; Wermer MJH; Schreuder FHBM; Klijn CJM; Verbeek MM
Ann Neurol; 2023 Jun; 93(6):1173-1186. PubMed ID: 36707720
[TBL] [Abstract][Full Text] [Related]
12. Aβ38 and Aβ43 do not differentiate between Alzheimer's disease and cerebral amyloid angiopathy.
Dargvainiene J; Jensen-Kondering U; Bender B; Berg D; Brüggemann N; Flüh C; Markewitz R; Neumann A; Röben B; Röcken C; Royl G; Schulte C; Wandinger KP; Weiler C; Margraf NG; Kuhlenbäumer G
Ann Clin Transl Neurol; 2024 Mar; 11(3):806-811. PubMed ID: 38186185
[TBL] [Abstract][Full Text] [Related]
13. Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features.
Renard D; Tatu L; Collombier L; Wacongne A; Ayrignac X; Charif M; Boukriche Y; Chiper L; Fourcade G; Azakri S; Gaillard N; Mercier E; Lehmann S; Thouvenot E
J Alzheimers Dis; 2018; 64(4):1113-1121. PubMed ID: 30010128
[TBL] [Abstract][Full Text] [Related]
14. Altered brain expression and cerebrospinal fluid levels of TIMP4 in cerebral amyloid angiopathy.
Jäkel L; De Kort AM; Stellingwerf A; Hernández Utrilla C; Kersten I; Vervuurt M; Vermeiren Y; Küsters B; Schreuder FHBM; Klijn CJM; Kuiperij HB; Verbeek MM
Acta Neuropathol Commun; 2024 Jun; 12(1):103. PubMed ID: 38915119
[TBL] [Abstract][Full Text] [Related]
15. Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.
Carmona-Iragui M; Balasa M; Benejam B; Alcolea D; Fernández S; Videla L; Sala I; Sánchez-Saudinós MB; Morenas-Rodriguez E; Ribosa-Nogué R; Illán-Gala I; Gonzalez-Ortiz S; Clarimón J; Schmitt F; Powell DK; Bosch B; Lladó A; Rafii MS; Head E; Molinuevo JL; Blesa R; Videla S; Lleó A; Sánchez-Valle R; Fortea J
Alzheimers Dement; 2017 Nov; 13(11):1251-1260. PubMed ID: 28463681
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.
Renard D; Collombier L; Demattei C; Wacongne A; Charif M; Ayrignac X; Azakri S; Gaillard N; Boudousq V; Lehmann S; Menjot de Champfleur N; Thouvenot E
J Alzheimers Dis; 2018; 61(3):1107-1117. PubMed ID: 29254099
[TBL] [Abstract][Full Text] [Related]
17. Cognitive
Perini G; Ramusino MC; Farina LM; Fabbro BD; Canavero I; Picascia M; Muzic S; Ballante E; Cavallini A; Pichiecchio A; Costa A
Curr Alzheimer Res; 2023; 20(4):267-276. PubMed ID: 37448371
[TBL] [Abstract][Full Text] [Related]
18. Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort.
Costa AS; Pinho J; Kučikienė D; Reich A; Schulz JB; Reetz K
J Alzheimers Dis; 2021; 79(4):1661-1672. PubMed ID: 33492291
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein D: a potential biomarker for cerebral amyloid angiopathy.
Kuiperij HB; Hondius DC; Kersten I; Versleijen AAM; Rozemuller AJM; Greenberg SM; Schreuder FHBM; Klijn CJM; Verbeek MM
Neuropathol Appl Neurobiol; 2020 Aug; 46(5):431-440. PubMed ID: 31872472
[TBL] [Abstract][Full Text] [Related]
20. Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics.
Muir RT; Ismail Z; Black SE; Smith EE
Alzheimers Dement; 2024 Feb; 20(2):1436-1458. PubMed ID: 37908054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
